#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Bulbospinal muscular atrophy congenital Anal fistula Cystic fibrosis gastrointestinal disease Cerebral arteriovenous malformation haemorrhagic Mucopolysaccharidosis III Neuroendocrine carcinoma metastatic Heavy menstrual bleeding Ocular lymphoma Activated PI3 kinase delta syndrome Loss of consciousness Homocystinuria Anal cancer Leiomyosarcoma Neuroendocrine carcinoma of the skin Chondrosarcoma More trials…

    Learn about Rare Diseases

    Cystic fibrosis lung Antisynthetase syndrome – Diagnostics Chondrosarcoma – Basic Information Basal cell naevus syndrome – Life with Disease Systemic sclerosis pulmonary – Life with Disease Congenital generalised lipodystrophy Antisynthetase syndrome – Basic Information Congenital hypotransferrinaemia – Life with Disease Loeys-Dietz syndrome – Trials in Disease Osteosarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ociperlimab Tiotropium Bromide Monohydrate Orismilast Olopatadine Vindesine Sulfate Leuprorelin Acetate GRNA1599 Isoflurane Tezepelumab Salmeterol Sodium Nitroprusside Dihydrate Ravulizumab Nefopam Hydrochloride N-Tec Propranolol Sitravatinib Malate Fezolinetant Estradiol Venlafaxine Mebendazole More therapies…

    Learn about Your Condition

    Malignant neoplasm of choroid Tourette's disorder Autoimmune hepatitis Open angle glaucoma Pharyngeal cancer stage I Large cell lung cancer stage 0 Laryngeal cancer stage I Magnetic resonance imaging Acute myeloid leukaemia Ehlers-Danlos syndrome Fatty acid oxidation disorder Death neonatal Basal cell carcinoma Choroid melanoma Sciatica More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Tebentafusp and Liver Radiotherapy for Patients with Metastatic Uveal Melanoma HLA A*02:01 Positive

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uveal melanoma
    Investigated Drugs:
    • Tebentafusp
    Italy

  • Efficacy and Safety Study of Paltusotine for Adults with Carcinoid Syndrome due to Well-Differentiated Neuroendocrine Tumors

    Recruiting

    3 1
    Investigated Drugs:
    • Paltusotine
    Belgium Denmark France Germany Ireland Italy +4

  • Study of Bleximenib, Venetoclax, and Azacitidine Treatment for Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • BLEXIMENIB
    • Azacitidine
    • Venetoclax
    Austria Belgium Czechia Denmark France Germany +6

  • Study Comparing Single and Dual Antiplatelet Therapy with Clopidogrel and Acetylsalicylic Acid in Elderly Patients or Those at Risk of Bleeding After Balloon Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Clopidogrel
    Belgium Italy Luxembourg Spain

  • Study of WSD0922-FU for Patients with Advanced Non-Small Cell Lung Cancer and C797S Mutation After Osimertinib Treatment

    Recruiting

    2 1 1
    France

  • Evaluation of SB-007 Safety and Efficacy in Patients with Stargardt Disease Type 1 (STGD1) Caused by ABCA4 Gene Mutations

    Recruiting

    2 1 1
    Investigated Drugs:
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, C-REGION
    • ADENO-ASSOCIATED VIRUS VECTOR SEROTYPE 8 ENCODING THE ABCA4 PROTEIN, N-REGION
    Belgium Germany
Previous Page
1 … 169 170 171 172 173 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!